Open Access Green as soon as Postprint is submitted to ZB.
Insights from a multi-centre real life experience in Germany with nintedanib for the Tteatment of idiopathic pulmonary fibrosis.
Am. J. Respir. Crit. Care Med. 193 (2016)
Publication type Article: Journal article
Document type Meeting abstract
Institute(s) Institute of Lung Biology (ILBD)